Dr. Keenan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1959 NE Pacific St
Seattle, WA 98195Phone+1 206-520-5000
Education & Training
- McGovern Medical School at UTHealthClass of 2016
Certifications & Licensure
- WA State Medical License 2023 - 2025
- TN State Medical License 2020 - 2024
- TX State Medical License 2018 - 2021
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 1 citationsDifferential effects of itacitinib, fedratinib, and ruxolitinib in mouse models of hemophagocytic lymphohistiocytosis.Camille Keenan, Sabrin Albeituni, Ninad Oak, Alexa Stroh, Heather S Tillman
Blood. 2024-06-06 - 76 citationsUse of the JAK Inhibitor Ruxolitinib in the Treatment of Hemophagocytic Lymphohistiocytosis.Camille Keenan, Kim E. Nichols, Sabrin Albeituni
Frontiers in Immunology. 2021-02-16 - 62 citationsHemophagocytic lymphohistiocytosis-like toxicity (carHLH) after CD19-specific CAR T-cell therapy.Melissa Hines, Camille Keenan, Gabriela Maria Marón Alfaro, Cheng Cheng, Yinmei Zhou
British Journal of Haematology. 2021-07-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: